Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma (Q36524705)

14 August 2017

1 reference

title

Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma (English)

1 reference

Adaptive radiation therapy

14 August 2017

0 references

author name string

Graham Stevens

series ordinal

1

1 reference

PubMed ID

16814209

14 August 2017

Michael J McKay

series ordinal

2

1 reference

14 August 2017

1 July 2006

1 reference

Lancet Oncology Commission

14 August 2017

1 reference

14 August 2017

7

1 reference

14 August 2017

7

1 reference

14 August 2017

575-583

1 reference

Management of cutaneous melanoma

14 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Improving outcomes in advanced malignant melanoma: update on systemic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Radiotherapy for malignant melanoma: A re-appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Action of x-rays on mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The radiosensitivity of melanoma cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The relationship between total dose, number of fractions and fractions size in the response of malignant melanoma in patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Radiation therapy of malignant melanoma: experience with high individual treatment doses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Some factors of importance in the radiation treatment of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The spectrum of in vitro radiosensitivity in four human melanoma cell lines is not accounted for by differential induction or rejoining of DNA double strand breaks.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Clinical radiobiology of malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Postoperative radiotherapy for cutaneous melanoma of the head and neck region.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Locally advanced melanoma: results of postoperative hypofractionated radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Fraction size in external beam radiation therapy in the treatment of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Desmoplastic melanoma: patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Desmoplastic neurotropic melanoma. A clinicopathologic analysis of 28 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Lymph-node metastases in patients with melanoma: what is the optimum management?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Controversies in the management of metastatic melanoma to regional lymphatic basins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Radiation therapy following lymph node dissection in melanoma patients: treatment, outcome and complications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Combined-modality therapy for patients with regional nodal metastases from melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Morbidity, mortality and local recurrence following regional node dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Local control following therapeutic nodal dissection for melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Loco-regional nodal relapse in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Adjuvant radiation therapy for regional nodal metastases from malignant melanoma. A randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma: toxicity and local control

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Adjuvant irradiation for axillary metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Radiation therapy for nodal disease in malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Nodal radiation therapy for metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Melanoma metastatic to cervical lymph nodes: Can radiotherapy replace formal dissection after local excision of nodal disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Radiation therapy following nodal surgery for melanoma: an analysis of late toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The rationale for adjuvant whole brain radiation therapy with radiosurgery in the treatment of single brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Determinants of outcome in melanoma patients with cerebral metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Therapeutic management of brain metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Temozolomide with or without radiotherapy in melanoma with unresectable brain metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Stereotactic radiosurgery for four or more intracranial metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

High-tech in radiation oncology: should there be a ceiling?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Is tomotherapy the future of IMRT?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

The relative costs of proton and X-ray radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Boron neutron capture therapy of cancer: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Targeted alpha therapy for cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Hyperthermia in combined treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Current imaging paradigms in radiation oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Genetic determinants of radiation response. Report on a symposium held at Peter MacCallum Cancer Institute, Melbourne, Australia, 8 August 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

Prediction of radiation sensitivity using a gene expression classifier

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

A challenge to traditional radiation oncology.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970758-6

7 January 2021

10.1016/S1470-2045(06)70758-6

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16814209